SmallCap
CompaniesMapStatistics

(주)모아라이프플러스

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)모아라이프플러스
English NameMOA Life Plus Co. Ltd.
Business Reg. No.3148129870
CEO한상진
Address경기도 용인시 수지구 신수로 767 7층 (동천동, 분당수지유타워 지식산업센터)
Industry의학 및 약학 연구개발업
Industry Code701
Main Products자궁경부상피이형증 치료제,자구경부전암 치료백신 연구개발/동물의약품 제조
Established19991230
Phone031-280-9650
Websitewww.bioleaders.co.kr
Regular Employees42persons
Corp. Reg. No.1601110091332

Investment Metrics


Market Cap
-
Op. Margin
-35.44%
ROE
-17.21%
Debt Ratio
53.68%

Certification Status


Venture Certified

Cert. History
연구개발기업2001-03-30 ~ 2003-03-290115350333010182001-03-30
연구개발기업2003-03-30 ~ 2005-03-290315350214000812001-03-30
연구개발기업2005-03-30 ~ 2007-03-290515220315000812001-03-30
연구개발유형2007-03-30 ~ 2009-03-29200701006522001-03-30
기술평가보증기업(기금)2009-03-30 ~ 2010-03-29200901028322001-03-30
기술평가보증기업(기금)2010-03-30 ~ 2012-03-29201001031332001-03-30
기술평가보증기업(기금)2012-03-30 ~ 2014-03-29201201042632001-03-30
기술평가보증기업(기금)2014-03-30 ~ 2016-03-29201401052602001-03-30
기술평가보증기업(기금)2016-03-30 ~ 2018-03-29201601040252001-03-30
연구개발유형2018-03-30 ~ 2020-03-29201801032412001-03-30
연구개발유형2020-03-30 ~ 2022-03-29202001046252001-03-30
혁신성장유형2022-03-30 ~ 2025-03-29202204140301062001-03-30
혁신성장유형2025-03-30 ~ 2028-03-29202504080300742001-03-30

Financial Statements


4-Year Financial Data

Revenue CAGR -46.3%

Item2024202320222021
Revenue

156B

182B

220B

1,012B

Operating Profit

-55B

-52B

-97B

-145B

Net Profit

-70B

81B

-337B

-358B

Total Assets

622B

491B

1,484B

1,888B

Total Liabilities

217B

133B

811B

905B

Total Equity

405B

358B

673B

983B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
156B

66.8%

vs. 3-Year Avg.: 471B
Operating Profit
-55B

43.4%

vs. 3-Year Avg.: -98B
Op. Margin
-35.4%

22.4%

vs. 3-Year Avg.: -28.9%
Debt Ratio
53.7%

35.5%

vs. 3-Year Avg.: 83.2%
ROE
-17.2%

19.2%

vs. 3-Year Avg.: -21.3%

Officers / Major Shareholders


NamePositionRoleComp. (M KRW)
한상진사내이사CEO-
윤상호사내이사COO-
이건웅사내이사CFO-
허익준감사감사-
ShareholderOwnership (%)Shares Held
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Employment Status


Regular Employees

42persons

CEO한상진

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "경기도 용인시",
  "ceo_name": "한상진",
  "certificate": [
    {
      "cert_number": "011535033301018",
      "changes": "",
      "disclosure_date": "2001-03-30",
      "first_cert_date": "2001-03-30",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "2001-03-30 ~ 2003-03-29"
    },
    {
      "cert_number": "031535021400081",
      "changes": "",
      "disclosure_date": "2003-03-30",
      "first_cert_date": "2001-03-30",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2003-03-30 ~ 2005-03-29"
    },
    {
      "cert_number": "051522031500081",
      "changes": "",
      "disclosure_date": "2005-03-30",
      "first_cert_date": "2001-03-30",
      "no": "3",
      "type": "연구개발기업",
      "valid_period": "2005-03-30 ~ 2007-03-29"
    },
    {
      "cert_number": "20070100652",
      "changes": "",
      "disclosure_date": "2007-03-26",
      "first_cert_date": "2001-03-30",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2007-03-30 ~ 2009-03-29"
    },
    {
      "cert_number": "20090102832",
      "changes": "",
      "disclosure_date": "2009-04-01",
      "first_cert_date": "2001-03-30",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-03-30 ~ 2010-03-29"
    },
    {
      "cert_number": "20100103133",
      "changes": "",
      "disclosure_date": "2010-04-01",
      "first_cert_date": "2001-03-30",
      "no": "6",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2010-03-30 ~ 2012-03-29"
    },
    {
      "cert_number": "20120104263",
      "changes": "",
      "disclosure_date": "2012-05-09",
      "first_cert_date": "2001-03-30",
      "no": "7",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-03-30 ~ 2014-03-29"
    },
    {
      "cert_number": "20140105260",
      "changes": "",
      "disclosure_date": "2014-05-02",
      "first_cert_date": "2001-03-30",
      "no": "8",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-03-30 ~ 2016-03-29"
    },
    {
      "cert_number": "20160104025",
      "changes": "",
      "disclosure_date": "2016-04-08",
      "first_cert_date": "2001-03-30",
      "no": "9",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-03-30 ~ 2018-03-29"
    },
    {
      "cert_number": "20180103241",
      "changes": "",
      "disclosure_date": "2018-03-27",
      "first_cert_date": "2001-03-30",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2018-03-30 ~ 2020-03-29"
    },
    {
      "cert_number": "20200104625",
      "changes": "",
      "disclosure_date": "2020-04-14",
      "first_cert_date": "2001-03-30",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2020-03-30 ~ 2022-03-29"
    },
    {
      "cert_number": "20220414030106",
      "changes": "",
      "disclosure_date": "2022-04-14",
      "first_cert_date": "2001-03-30",
      "no": "12",
      "type": "혁신성장유형",
      "valid_period": "2022-03-30 ~ 2025-03-29"
    },
    {
      "cert_number": "20250408030074",
      "changes": "",
      "disclosure_date": "2025-04-08",
      "first_cert_date": "2001-03-30",
      "no": "13",
      "type": "혁신성장유형",
      "valid_period": "2025-03-30 ~ 2028-03-29"
    }
  ],
  "company_name": "주식회사 모아라이프플러스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 16013874000,
      "cost_of_sales": 15103307000,
      "current_assets": 30690316000,
      "current_liabilities": 21442573000,
      "gross_profit": 6901030000,
      "net_income": -28277277000,
      "net_income_bs": -28277277000,
      "non_current_assets": 35941882000,
      "non_current_liabilities": 1340733000,
      "non_operating_expenses": 23991688000,
      "non_operating_income": 4526421000,
      "operating_profit": -8812010000,
      "revenue": 22004336000,
      "sga_expenses": 15713039000,
      "total_assets": 66632198000,
      "total_equity": 43848891000,
      "total_liabilities": 22783306000
    },
    "2023": {
      "capital_stock": 16137521000,
      "cost_of_sales": 12664212000,
      "current_assets": 20898577000,
      "current_liabilities": 12451906000,
      "gross_profit": 5581105000,
      "net_income": -8539824000,
      "net_income_bs": -8539824000,
      "non_current_assets": 25338497000,
      "non_current_liabilities": 752711000,
      "non_operating_expenses": 7453668000,
      "non_operating_income": 3651356000,
      "operating_profit": -4737512000,
      "revenue": 18245316000,
      "sga_expenses": 10318616000,
      "total_assets": 46237075000,
      "total_equity": 33032457000,
      "total_liabilities": 13204617000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "자궁경부상피이형증 치료제,자구경부전암 치료백신 연구개발/동물의약품 제조",
  "phone": "031-280-****",
  "years": [
    2023,
    2022
  ]
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsDART
Collected
Investment MetricsDART
Collected
OfficersDART
Collected
EmploymentDART
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
DART Financial2026-02-27
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Employment Insurance2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected